For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| AI (Test) Abdomen | AI (Test) Abdomen: 2× 1mL (total 200 mg mirikizumab) administered by subcutaneous injection (SC) via an autoinjector (AI). | 0 | None | 0 | 40 | 7 | 40 | View |
| AI (Test) Arm | AI (Test) Arm: 2× 1mL (total 200 mg mirikizumab) administered by subcutaneous injection (SC) via an autoinjector (AI). | 0 | None | 0 | 39 | 6 | 39 | View |
| AI (Test) Thigh | AI (Test) Thigh: 2× 1mL (total 200 mg mirikizumab) administered by subcutaneous injection (SC) via an autoinjector (AI). | 0 | None | 0 | 41 | 8 | 41 | View |
| PFS (Reference) Abdomen | PFS (Reference) Abdomen: 2× 1mL (total 200 mg mirikizumab) administered by subcutaneous injection (SC) via a prefilled syringe (PFS). | 0 | None | 0 | 40 | 6 | 40 | View |
| PFS (Reference) Arm | PFS (Reference) Arm: 2× 1mL (total 200 mg mirikizumab) administered by subcutaneous injection (SC) via a prefilled syringe (PFS). | 0 | None | 0 | 41 | 5 | 41 | View |
| PFS (Reference) Thigh | PFS (Reference) Thigh: 2× 1mL (total 200 mg mirikizumab) administered by subcutaneous injection (SC) via a prefilled syringe (PFS). | 0 | None | 0 | 39 | 6 | 39 | View |